Pss25 - Cost-Effectiveness Analysis of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema (Dme) Under the Brazilian Public Healthcare System (Sus)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2525
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV